JPMorgan Downgrades Integra LifeSciences (IART) to Neutral

October 27, 2017 4:41 AM

JPMorgan downgraded Integra LifeSciences (NASDAQ: IART) from Overweight to Neutral with a price target of $44.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found